Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2022 · research · Fall 2021 RFA: Promoting Diversity, Equity and Inclusion in Parkinson’s Disease Research
Disparities in Neurocognitive Impairment Among Hispanics and Latinos in the United States with Parkinson’s Disease: The Role of Cardiovascular Risk
María J. Marquine · University of California San Diego
2022 · research · Research Grant
Examining the Role of Cannabinoid Receptor 2 in Inflammatory Responses Triggered by Alpha-synuclein
Valerie Joers · University of Florida
2022 · research · Diversity, Equity and Inclusivity in Parkinson's research
Engaging the LGBTQIA+ Community, Caregivers and Care Providers in Research on Living with Parkinson’s Disease
Jason D. Flatt · University of Nevada, Las Vegas
2022 · research · Summer 2022 RFP: Accelerating the Translation of Parkinson's Disease Therapies
Validation of a Novel Mitochondrial Drug Target for Parkinson’s Disease
Neil Derek Miller · Nrg Therapeutics Ltd
2022 · research · Fall 2020 RFA: Therapeutic Pipeline Program-Pre-Clinical
Assessing a Novel Strategy for Noninvasive Stimulation of Dopamine-producing Neurons in Preclinical Models of Parkinson’s Disease
Fabio Benfenati · Italian Institute of Technology
2022 · research · Parkinson’s Pathway Molecular Data Analysis Program
Assessment of Proinflammatory Cytokines as Biomarkers for Parkinson’s Disease
Valentina Escott-Price · Cardiff University
2022 · research · Research Grant
Development of PET Tracer for Imaging SV2C in Parkinson's Disease
Christer Halldin · Karolinska Institutet
2022 · research · Research Grant
Performing a First-In-Human Study of a Retinal Tracer For Alpha-synuclein in Parkinson's Disease
Stella Sarraf · Amydis (United States)
2022 · research · Research Grant
Developing a Strategy to Determine Why Melanoma and Parkinson's Disease Occur Together
Deanna L. Benson · Icahn School of Medicine at Mount Sinai
2022 · research · Diversity, Equity and Inclusivity in Parkinson's research
Promoting Diversity, Equity and Inclusion in Parkinson’s Disease (PD) Research: Clinical Disease Course and Healthcare Access in Black People with PD
Tao Xie · University of Chicago Medical Center
2022 · research · Research Grant
Undiagnosed Parkinson’s in the Emergency Department: An Opportunity for Early Intervention
Matthew R. Lewin · California Academy of Sciences
2022 · research · Expanding Biological Understanding of Parkinson's Disease
Evaluating the Role of Miro1 in Mitochondrial Quality Control in Parkinson’s Disease
Julia Catherine Fitzgerald · Hertie Institute for Clinical Brain Research
2022 · research · Proof-of-Concept Testing of PD Therapeutics
Using Data from the LEAPS Project to Improve the Accuracy of Assays that Measure Alpha-synuclein
Deniz Kirik · Lund University
2022 · research · Research Resources
Neural Network Imaging Analysis in Parkinson’s Disease Associated with Parkin Mutation
Jennifer A. Johnston · Nysnobio
2022 · research · Fall 2021 RFA: Promoting Diversity, Equity and Inclusion in Parkinson’s Disease Research
Preventing Fractures in Parkinson’s Disease by Identifying Barriers to Care and Social Determinants of Health
Alejandra Camacho-Soto · Washington University in St. Louis
2022 · research · Research Grant
Longitudinal Endpoint Optimization to Provide an Assessment of Relevant Drugs in Parkinson’s Disease (LEOPARD-PD)
Chad Rydel Heatwole · University of Rochester
2022 · research · Outcome Measures
Improving the generalizability and robustness of MRI-derived biomarkers of Parkinson's Disease through analytical and data variability evaluations
Tristan Glatard · Concordia University
2022 · research · Research Grant
Development of a Safe and Efficient Method to Treat Parkinson’s Disease Using RNA-based Gene Therapy
Robert Klein · Addition Therapeutics
2022 · research · Translational Pipeline Program
Investigating GPR55 as a Novel Neuroprotective Target in Preclinical Models of Parkinson’s Disease
Javier Fernández-Ruiz · Instituto Universitario De Investigación En Neuroquímica, Universidad Complutense; Centro De Investi
2022 · research · Research Grant
Identifying Bothersome Symptoms, Impacts of Disease and Relevance of WATCH-PD Digital Measures Over Time in Early Parkinson’s Disease
Jamie L. Adams · University of Rochester
2022 · research · Spring 2022 RFA: Target Advancement Program - Target Validation
Evaluating an Insulin-degrading Enzyme as a Novel Therapeutic Target for Parkinson’s Disease
Hugo Miguel Vicente Miranda · Universidade Nova de Lisboa
2022 · research · Therapeutic Pipeline Program
Evaluating the Efficacy of a mGluR5 Modulator in Preclinical Models of Parkinson’s Disease
Timothy R. Siegert
2022 · research · Research Grant
LEARN-ATMP – Using the Patient Voice to Develop a Framework for Accessible ATMP Trials
Emma Lane · Cardiff University
2022 · research · Research Grant
(Supplement) Self-reported Perceptions and Self-reported Outcomes on Motor and Non-motor Symptoms in the Parkinson's Disease Continuum: A Systematic Review of Mixed Methods
Michelle Hyczy De Siqueira Tosin · Rush University Medical Center
2022 · research · MJFF Funded Study
Uncovering Proteomic Alterations in Parkinson’s Disease Using Patient-specific iPSC-derived Brain Cells
Laurent Roybon · Van Andel Institute
2022 · research · Research Grant
Establishing a Parkinson’s Disease Registry in West Virginia
Helen M. Matheny · West Virginia University
2022 · research · Accelerating the Translation of Parkinson's Disease Therapies
Esya PD360: A Multi-parametric Platform for Establishing a Novel Lysosome-based Biomarker and Identifying Therapeutic Interventions for Parkinson’s Disease
Souvik Modi · Esya Ltd.
2022 · research · Summer 2022 RFP: Accelerating the Translation of Parkinson's Disease Therapies
Developing an Inhibitor of Transglutaminase 2 as a Disease-modifying Treatment for Parkinson’s Disease
Mary Maral Mouradian · William Dow Lovett Professor Of Neurology; Director Of The Rwjms Institute For Neurological Therapeutics; And Vice Chancellor For Faculty Development, Rutgers Biomedical And Health Sciences - Robert Wood Johnson Medical School
2022 · research · Fall 2021 RFP: Outcome Measures
Common Mitochondrial DNA Deletions as a Peripheral Marker of Parkinson’s Disease
Julia Catherine Fitzgerald · Hertie Institute for Clinical Brain Research
2022 · research · Research Grant
Shoring Up a Medical Chemistry Approach to Treating Parkinson’s Disease: The Bridge Initiative
Friederike Zunke · Universitätsklinikum Erlangen, Department Of Molecular Neurology
2022 · research · Fall 2021 RFP: Expanding Biological Understanding of PD
Exploring How Mutations in Genes Associated with Parkinson’s Disease Alter the Activity of Other Genes
Justin M. O'Sullivan · University of Auckland
2022 · research · 2022: Accelerated Therapeutics Program
Preclinical and Early Clinical Development of NPT1220-478 for the Treatment of Parkinson's Disease
Douglas W. Bonhaus · Neuropore Therapies, Inc.
2022 · research · Summer 2022 RFP: The Edmond J. Safra Movement Disorders Research Career Development Award
Tracking Eye Movements and Pupil Responses as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
Conor Fearon · Mater Misericordiae University Hospital
2022 · research · Research Grant
Creation and Testing of a Combined Cognitive Score in Parkinson Disease
Daniel Weintraub · University of Pennsylvania
2022 · research · Target Advancement Program
Development of an Antibody for Isolating Mitochondria from Preclinical Models and Individuals with Parkinson’s Disease
Miratul Muqit · University of Dundee
2022 · research · Alpha-synuclein Seed Amplification Assay Program
Digital Detection of Alpha-synuclein Aggregates for the Quantitative Diagnosis of Parkinson’s disease
Simone Hornemann · University of Zurich
2022 · research · [RFA] Use of PD Biosamples - Spring 2020
Studying DNA Methylation in Parkinson’s Disease Using the Systemic Synuclein Sampling Study
Beate Ritz · University of California, Los Angeles
2022 · research · Expanding Biological Understanding of PD
Identifying Genes that Enhance the Activity of Glucocerebrosidase
Adriano Aguzzie · University of Zurich
2022 · research · Research Grant
Assessing the Aggregation of Alpha-synuclein in the Gastrointestinal Tract
Thomas Beach · Banner Sun Health Research Institute
2022 · research · Fall 2021 RFP: Outcome Measures